Clearmind Medicine (CMND) holder HRT Financial LP sells 3,183 shares

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of Clearmind Medicine Inc., reported an open-market sale of 3,183 shares of Common Stock at $3.32 per share. After this transaction, HRT Financial LP directly holds 103,492 Clearmind Medicine common shares, indicating it retained the vast majority of its position.

Insider Trade Summary

Net Seller: 3,183 shares ($10,568)

Net Sell 1 txn

Insider HRT FINANCIAL LP

Role null

Sold 3,183 shs ($11K)

Type	Security	Shares	Price	Value
Sale	Common Stock	3,183	$3.32	$11K

Holdings After Transaction: Common Stock — 103,492 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 3,183 shares Sale price per share: $3.32 per share Shares held after transaction: 103,492 shares +1 more

4 metrics

Shares sold 3,183 shares Open-market sale of Clearmind Medicine common stock

Sale price per share $3.32 per share Price received in the 3,183-share sale

Shares held after transaction 103,492 shares Direct holdings of HRT Financial LP following the sale

Net shares sold 3,183 shares Net selling activity reported in the Form 4

Key Terms

open-market sale, ten percent owner, Common Stock, non-derivative

4 terms

open-market sale financial

"The transaction is described as an open-market sale of Common Stock."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner financial

"HRT Financial LP is identified as a ten percent owner of the issuer."

Common Stock financial

"The security title for the transaction is listed as Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"The transaction type is recorded as non-derivative, involving only common shares."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/17/2026 - 04:43 PM Accepted by SEC EDGAR 06/17/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clearmind Medicine Inc. [ CMND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		S		3,183	D	$3.32	103,492	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did HRT Financial LP do in this Clearmind Medicine (CMND) Form 4 filing?

HRT Financial LP reported an open-market sale of 3,183 Clearmind Medicine common shares. The shares were sold at $3.32 each, and the filing classifies the transaction as a standard sale of non-derivative Common Stock.

How many Clearmind Medicine (CMND) shares did HRT Financial LP sell and at what price?

HRT Financial LP sold 3,183 Clearmind Medicine common shares at a price of $3.32 per share. This was a non-derivative, open-market transaction classified under code “S” for a sale.

How many Clearmind Medicine (CMND) shares does HRT Financial LP hold after the sale?

Following the reported sale, HRT Financial LP directly holds 103,492 Clearmind Medicine common shares. This post-transaction figure shows the position remaining after disposing of 3,183 shares in the open market.

What type of security did HRT Financial LP trade in Clearmind Medicine (CMND)?

HRT Financial LP traded Clearmind Medicine Common Stock in this Form 4 filing. The transaction involved non-derivative shares, meaning no options or other derivatives were exercised or converted as part of this sale.

How is the transaction in Clearmind Medicine (CMND) classified in the Form 4?

The transaction is classified with code “S,” described as a sale in an open market or private transaction. The filing further labels it as an open-market sale and identifies the direction as a sell of non-derivative common shares.